9CB3 image
Entry Detail
PDB ID:
9CB3
EMDB ID:
Keywords:
Title:
E2F1-Cyclin F Interface
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2024-06-18
Release Date:
2025-02-12
Method Details:
Experimental Method:
Resolution:
3.47 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Cyclin-F
Chain IDs:A
Chain Length:636
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:S-phase kinase-associated protein 1
Chain IDs:B
Chain Length:163
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:E2F1 peptide
Chain IDs:C
Chain Length:13
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structural mechanism for recognition of E2F1 by the ubiquitin ligase adaptor Cyclin F.
Biorxiv ? ? ? (2025)
PMID: 39868286 DOI: 10.1101/2025.01.15.633208

Abstact

Cyclin F, a non-canonical member of the cyclin protein family, plays a critical role in regulating the precise transitions of cell-cycle events. Unlike canonical cyclins, which bind and activate cyclin-dependent kinases (CDKs), Cyclin F functions as a substrate receptor protein within the Skp1-Cullin-F box (SCF) E3 ubiquitin ligase complex, enabling the ubiquitylation of target proteins. The structural features that distinguish Cyclin F as a ligase adaptor and the mechanisms underlying its selective substrate recruitment over Cyclin A, which functions in complex with CDK2 at a similar time in the cell cycle, remain largely unexplored. We utilized single-particle cryo-electron microscopy to elucidate the structure of a Cyclin F-Skp1 complex bound to an E2F1 peptide. The structure and biochemical analysis reveal important differences in the substrate-binding site of Cyclin F compared to Cyclin A. Our findings expand on the canonical cyclin-binding motif (Cy or RxL) and highlight the importance of electrostatics at the E2F1 binding interface, which varies for Cyclin F and Cyclin A. Our results advance our understanding of E2F1 regulation and may inform the development of inhibitors targeting Cyclin F.

Legend

Protein

Chemical

Disease

Primary Citation of related structures